… Further, plasma p-tau217 might have the potential to predict … brain abnormalities associated
with Alzheimer's disease. … , showing that plasma p-tau181 levels are not as high as plasma p-…

… In a subset of 26 participants, we also analyzed antemortem levels of plasma p-tau181
and neurofilament light (NfL). Reference biomarker values were obtained from 146 amyloid-PET–…

… . Development and assessment of a composite score for memory in the Alzheimer's
disease neuroimaging Initiative (ADNI). Brain Imaging Behav 2012;6:502–16.doi:10.1007/s11682-…

… Our findings support that plasma GFAP and p-tau181 may contain the most independent
and complementary information among the four marker measures as both were chosen across …

… We found p-tau-217 and p-tau-181 were highly specific for amyloid plaque pathology in the
discovery cohort (n = 36, AUROC = 0.99 and 0.98 respectively). In the validation cohort (n = …

… Plasma p‐tau181/Aβ 1‐42 ratio correlated with cerebrospinal fluid (CSF) p‐tau181 (Elecsys,
Spearman's ρ = 0.74, P … The p‐tau181/Aβ 1‐42 ratio also predicted future rates of cognitive …

… -tau217 are indicators of both amyloid and tau pathology across the clinical Alzheimer’s
disease (AD) spectrum and can differentiate AD dementia from other neurodegenerative …

… p-tau181 may become abnormal earlier than tau-PET, which was demonstrated previously
among Alzheimer’s Disease … discrepancies between plasma p-tau181 and CSF p-tau181 or …

… that measurement of plasma phosphorylated tau species (P-tau181, P-tau217, and P-tau231) …
A recent study showed that, while both plasma P-tau181 and plasma NFL distinguished …

… We compared CSF p-tau217 to CSF p-tau181 in the Swedish BioFINDER-1 cohort (n=194).
We next evaluated plasma p-tau217 and plasma p-tau181 in three cohorts with 1,438 …